Why Denali Therapeutics Stock Is Soaring Today
Shares of Denali Therapeutics (NASDAQ: DNLI), a biopharmaceutical company focused on neurodegenerative diseases, rose 24% as of 2:36 p.m. EST on Tuesday in response to announcing that its pipeline is progressing.
Here are the key takeaways for investors:
Image source: Getty Images.
Source Fool.com
